Skip to main content
FRMSL logo

FRMSL — Investor Relations & Filings

Ticker · 4746 ISIN · TW0004746003 TW Manufacturing
Open in API
Filings indexed 1,872 across all filing types
Latest filing 2023-05-15 Investor Presentation
Country TW Taiwan
Listing TW 4746

About FRMSL

www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
112年05月法人說明會簡報 — 474620230515E001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation dated May 15, 2023, from Formosa Laboratories Inc. It includes extensive operational results up to April 2023, business strategy, product categories, profitability data, manufacturing updates, and future outlook. The content is structured as a slide presentation with charts and business updates, typical of investor or analyst presentations. There is no indication that this is a formal annual or quarterly report, audit report, or regulatory filing. It is not a transcript of a call, nor a voting or dividend announcement. The presence of forward-looking statements, business strategy, and operational highlights strongly suggests this is an Investor Presentation (IP). The document length and detail support this classification with high confidence.
2023-05-15 Chinese
112年05月法人說明會簡報 — 474620230515M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation dated May 15, 2023, containing operational performance data up to April 2023, business strategy, product line descriptions, sales highlights, and development plans. It includes financial metrics such as revenue growth, profit margins, and product market shares, but it is structured as a slide presentation with charts and bullet points rather than a formal financial report. The presence of a Q&A section at the end further supports that this is a presentation format. There is no indication that this is an official annual or quarterly report, audit report, or regulatory filing. The content aligns with an investor presentation focusing on financials, strategy, and market position.
2023-05-15 Chinese
112年05月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled '法人說明會' which translates to 'investor presentation' or 'analyst briefing'. It includes company code, name, date, time, location, summary of the presentation, and links to presentation materials in PDF format. The content is clearly about an upcoming or recent investor presentation event, not a full financial report or earnings release. The document length is short (729 characters) and it provides links to presentation files rather than containing detailed financial data itself. Therefore, the document fits the category of Investor Presentation (IP).
2023-05-15 Chinese
112年第1季海外子公司投資
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data related to investment holdings and equity method accounting for overseas subsidiaries, including investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (112年1季, which corresponds to Q1 of the year 112 in the Taiwanese calendar). The content is numerical and substantive, indicating it is a financial report for a period shorter than a full fiscal year. The document length is under 5,000 characters but contains actual financial data, so it is not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-05-12 Chinese
112年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment amounts, and recognized investment gains. The document is relatively short (1288 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or earnings release. There is no indication of it being an annual or quarterly report, audit report, or earnings release. It is a regulatory filing providing specific investment data as required by authorities, fitting best under the category of Regulatory Filings (RNS).
2023-05-12 Chinese
112年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for the first quarter of the fiscal year 112 (which corresponds to 2023 in the Taiwanese calendar). It includes line items such as common stock, capital surplus, legal reserve, retained earnings, and other equity components, with comparative data for the previous year's same quarter. The document is about a quarterly period and contains substantive financial data and analysis, not just an announcement or summary. The length is 3269 characters, which is relatively short but sufficient for a quarterly equity statement. Given the content and period, this fits the definition of an Interim / Quarterly Report (IR).
2023-05-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.